First Heartland Consultants’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-955
| Closed | -$298K | – | 506 |
|
|
2025
Q1 | $298K | Sell |
955
-1,462
| -60% | -$432K | 0.03% | 343 |
|
|
2024
Q4 | $630K | Sell |
2,417
-28
| -1% | -$8.31K | 0.06% | 203 |
|
|
2024
Q3 | $788K | Sell |
2,445
-104
| -4% | -$34K | 0.08% | 167 |
|
|
2024
Q2 | $796 | Sell |
2,549
-17
| -0.7% | -$4.99K | 0.06% | 198 |
|
|
2024
Q1 | $730K | Sell |
2,566
-11
| -0.4% | -$3.22K | 0.08% | 200 |
|
|
2023
Q4 | $742K | Buy |
2,577
+1
| +0% | +$272 | 0.09% | 171 |
|
|
2023
Q3 | $692K | Hold |
2,576
| – | – | 0.09% | 171 |
|
|
2023
Q2 | $572K | Sell |
2,576
-50
| -2% | -$11.6K | 0.07% | 193 |
|
|
2023
Q1 | $635K | Buy |
2,626
+2
| +0.1% | +$491 | 0.1% | 176 |
|
|
2022
Q4 | $689K | Buy |
2,624
+10
| +0.4% | +$2.68K | 0.11% | 161 |
|
|
2022
Q3 | $589 | Buy |
2,614
+50
| +2% | +$12.1K | 0.05% | 167 |
|
|
2022
Q2 | $623K | Buy |
2,564
+27
| +1% | +$6.62K | 0.1% | 162 |
|
|
2022
Q1 | $613K | Buy |
2,537
+21
| +0.8% | +$4.83K | 0.1% | 160 |
|
|
2021
Q4 | $566 | Buy |
2,516
+454
| +22% | +$95.8K | 0.02% | 178 |
|
|
2021
Q3 | $439K | Sell |
2,062
-232
| -10% | -$53.4K | 0.07% | 224 |
|
|
2021
Q2 | $559K | Sell |
2,294
-431
| -16% | -$106K | 0.08% | 195 |
|
|
2021
Q1 | $678K | Buy |
2,725
+199
| +8% | +$47.5K | 0.11% | 163 |
|
|
2020
Q4 | $581K | Sell |
2,526
-398
| -14% | -$91.8K | 0.1% | 152 |
|
|
2020
Q3 | $743K | Sell |
2,924
-19
| -0.6% | -$4.71K | 0.14% | 110 |
|
|
2020
Q2 | $694K | Buy |
2,943
+13
| +0.4% | +$2.97K | 0.14% | 123 |
|
|
2020
Q1 | $594K | Sell |
2,930
-150
| -5% | -$32.8K | 0.15% | 122 |
|
|
2019
Q4 | $743K | Buy |
3,080
+134
| +5% | +$29.5K | 0.15% | 141 |
|
|
2019
Q3 | $570K | Sell |
2,946
-308
| -9% | -$59.1K | 0.12% | 144 |
|
|
2019
Q2 | $600K | Buy |
3,254
+81
| +3% | +$14.5K | 0.14% | 131 |
|
|
2019
Q1 | $603K | Sell |
3,173
-20
| -0.6% | -$3.82K | 0.17% | 131 |
|
|
2018
Q4 | $622K | Sell |
3,193
-6
| -0.2% | -$1.17K | 0.23% | 102 |
|
|
2018
Q3 | $663K | Sell |
3,199
-39
| -1% | -$7.69K | 0.21% | 108 |
|
|
2018
Q2 | $598K | Sell |
3,238
-460
| -12% | -$81.4K | 0.21% | 117 |
|
|
2018
Q1 | $630K | Buy |
3,698
+991
| +37% | +$182K | 0.19% | 127 |
|
|
2017
Q4 | $471K | Sell |
2,707
-2,028
| -43% | -$359K | 0.14% | 160 |
|
|
2017
Q3 | $883K | Sell |
4,735
-922
| -16% | -$163K | 0.21% | 134 |
|
|
2017
Q2 | $974K | Buy |
5,657
+327
| +6% | +$53.2K | 0.25% | 115 |
|
|
2017
Q1 | $875K | Buy |
5,330
+1,230
| +30% | +$204K | 0.24% | 116 |
|
|
2016
Q4 | $599K | Sell |
4,100
-1,676
| -29% | -$252K | 0.18% | 152 |
|
|
2016
Q3 | $963K | Sell |
5,776
-185
| -3% | -$31.3K | 0.28% | 94 |
|
|
2016
Q2 | $907 | Buy |
5,961
+3,757
| +170% | +$584K | 0.1% | 92 |
|
|
2016
Q1 | $330K | Sell |
2,204
-95
| -4% | -$14.1K | 0.13% | 184 |
|
|
2015
Q4 | $373K | Buy |
2,299
+33
| +1% | +$5.19K | 0.14% | 171 |
|
|
2015
Q3 | $313K | Buy |
2,266
+131
| +6% | +$20.6K | 0.13% | 175 |
|
|
2015
Q2 | $328 | Buy |
2,135
+97
| +5% | +$15.5K | 0.09% | 183 |
|
|
2015
Q1 | $326K | Sell |
2,038
-412
| -17% | -$64.9K | 0.12% | 181 |
|
|
2014
Q4 | $390K | Buy |
2,450
+271
| +12% | +$42.2K | 0.16% | 160 |
|
|
2014
Q3 | $306K | Sell |
2,179
-254
| -10% | -$33.2K | 0.13% | 177 |
|
|
2014
Q2 | $288K | Sell |
2,433
-264
| -10% | -$30.6K | 0.13% | 178 |
|
|
2014
Q1 | $333K | Sell |
2,697
-199
| -7% | -$24.1K | 0.16% | 158 |
|
|
2013
Q4 | $330K | Buy |
2,896
+2
| +0.1% | +$228 | 0.19% | 132 |
|
|
2013
Q3 | $332K | Sell |
2,894
-90
| -3% | -$9.76K | 0.2% | 146 |
|
|
2013
Q2 | $294K | Buy |
+2,984
| New | +$310K | 0.17% | 155 |
|
Other funds holding AMGN
First Heartland Consultants's AMGN Position: Q2 2025 in Review
First Heartland Consultants sold out of Amgen (AMGN) in Q2 2025, closing a stake of 955 shares — an estimated $298K sold.
First Heartland Consultants first reported a position in AMGN in Q2 2013 and held it in 48 quarters. The position peaked at $974K in Q2 2017. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.
- First Heartland Consultants reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
- First Heartland Consultants sold 955 Amgen shares in Q2 2025, an estimated $298K.
- First Heartland Consultants first reported a position in Amgen in Q2 2013 and held it in 48 quarters.
- First Heartland Consultants's Amgen position peaked at $974K in Q2 2017.
- 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.
Based on First Heartland Consultants's 13F filing for Q2 2025, filed 15 Aug 2025.